Prognostic value of circulating tumour cells in limited-disease small cell lung ancer patients treated on the CONVERT trial.

Fabiola Fernandez-Gutierrez, Victoria Foy, Katy Burns, Jacqueline Pierce, Karen Morris, L Priest, Jonathan Tugwood, L Ashcroft, Corinne Faivre-Finn, Caroline Dive, Fiona Blackhall

Research output: Contribution to conferenceAbstractpeer-review

Original languageEnglish
PagesS134
Publication statusPublished - 2017

Research Beacons, Institutes and Platforms

  • Manchester Cancer Research Centre

Cite this